Kelly Hagman is driven by a passion for advancing genomic medicine through evidence and strategy, making her an ideal fit for her role as Vice President of Medical Affairs at Ambry Genetics. In this position, , Kelly established the company’s first Medical Affairs department, uniting clinical leaders and driving long-term strategic planning. Kelly oversees teams spanning Clinical Strategy, Clinical Research, Education, and our field-facing Genomic Science Liaisons ensuring clinical strategy enhances innovation and industry engagement. With over 25 years of experience in the clinical laboratory industry and over 50 peer-reviewed publications, Kelly has led transformative initiatives, including launching the industry’s first clinical exome and co-authoring ACMG/AMP guidelines, demonstrating a sustained commitment to advancing genomic medicine.